Spero Therapeutics (SPRO) FCF Margin (QoQ) (2017 - 2026)
Spero Therapeutics (SPRO) FCF Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Spero Therapeutics | 70.14 Mn | 19.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 608,413.00 |
| Dec 31, 2025 | -25,543.00 |
| Sep 30, 2025 | 44,483.00 |
| Jun 30, 2025 | -5,656.00 |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | -6.46 Mn |
| Sep 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | -442,525.00 |
| Mar 31, 2024 | 418,178.00 |
| Dec 31, 2023 | -283.00 |
| Sep 30, 2023 | 74,598.00 |
| Jun 30, 2023 | 508,017.00 |
| Mar 31, 2023 | -602,885.00 |
| Dec 31, 2022 | 35,362.00 |
| Sep 30, 2022 | 248,220.00 |
| Jun 30, 2022 | 885,567.00 |
| Mar 31, 2022 | -1.16 Mn |
| Dec 31, 2021 | 91,925.00 |
| Sep 30, 2021 | -37,762.00 |
| Jun 30, 2021 | -10,977.00 |